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Congenital heart disease remains the most importantcause of death in the first year after birth.1
Mortality occurs mainly in patients with severe forms
798
of congenital heart disease requiring immediate surgi-
cal intervention. Secondary to the improvement of
surgical techniques over the last years, mortality has
decreased dramatically, but important neurologic
sequelae have been noted that may affect the quality
of survival.2-4 Perfection of operative techniques has
resulted in only minimal operative mortality and mor-
bidity compared with the preoperative risk factors, as
described by Soongswang and colleagues.5 Achieving
a further decrease in mortality and morbidity will pre-
dominantly require improved preoperative stabiliza-
tion of the patient.5,6 We hypothesize that the prenatal
diagnosis of congenital heart disease facilitates the
initiation of therapeutic intervention immediately
after birth, including planned delivery at a cardiac
center and immediate postnatal stabilization, which
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may include the initiation of prostaglandin therapy7
and intubation and ventilation if required. These
measures may prevent neonatal hypoxemia, hypoper-
fusion, and acidosis. A salutary effect of prenatal car-
diac diagnosis on neonatal survival has been proven
for transposition of the great arteries by Bonnet and
colleagues.8 This is the only article in the literature
thus far that has the statistical power to show this
effect. Some studies suggest improved outcomes in
some subgroups of patients with prenatally diag-
nosed congenital heart disease.9-12 A significant
effect on the overall group of patients with structural
heart disease has not been shown. The purpose of this
study was to evaluate retrospectively the effect of
prenatal diagnosis on the newborn with congenital
heart disease, comparing the incidence of metabolic
acidosis in prenatally and postnatally diagnosed
groups of patients with similar diagnoses.
Patients and methods
This retrospective study included patients diagnosed with
congenital heart disease between January 1, 1991, and July
30, 1998, originating from 3 institutions: the University
Medical Center, Utrecht, The Netherlands; Yale–New Haven
Children’s Hospital; and University of Maryland Medical
System in Baltimore. All patients who required operations for
structural heart disease in the first 31 days of life or died
before the operation could take place were included.
Excluded were patients with severe, life-threatening extracar-
diac or chromosomal anomalies.
Two different groups of patients with structural heart dis-
ease were compared, one in which the diagnosis was made
prenatally and the other in which the cardiac anomaly was
discovered after birth. Both groups received similar care at
the same institutions.
The patients having a prenatal diagnosis were delivered
within the University Hospitals, where indicated prosta-
glandin was started immediately and infants were intubated
and ventilated if needed. The other patients were treated after
congenital heart disease was suspected.
Outcome variables. Medical records were reviewed for
age at diagnosis, mode of delivery, gestational age at delivery,
Apgar scores, prostaglandin administration, and laboratory
values, including arterial pH, base excess (BE), PCO2, PO2,
and, if measured, lactate values. Arterial blood gases were
those reported at 1 and 4 to 6 hours postpartum and worst
blood gas, regardless of postnatal age in hours. These data
were used to compare not only the 2 different groups
described above but also to compare several sets of sub-
groups, including patients with and without ductus-depen-
dent lesions, patients with a future possibility of biventricular
repair, and those with an anticipated single ventricular repair.
The outcomes in patients with left ventricular outflow tract
obstruction, right ventricular outflow tract obstruction, and
without any obstruction were compared separately.
Statistical analysis. Data were analyzed by using SPSS
software (SPSS, Inc, Chicago, Ill). The Student t test was
used for comparing both groups for values of pH, BE, PCO2,
PO2, and lactate values. χ2 Testing was used for comparison
of both groups with regard to univentricular or biventricular
repair, ductus dependency, and mode of delivery.
Results
Between January 1, 1991, and June 30, 1998, 408
patients with congenital heart disease requiring oper-
ations within 31 days of life were admitted to the 3
participating institutions. Prenatal diagnosis in this
group was established in 81 (20%) patients at an aver-
age gestational age of 30.5 weeks, whereas 327 (80%)
patients only had postnatal diagnosis of their heart
disease. Cesarean delivery was performed in 30.4% of
the prenatal cases and 21.8% of the postnatal cases 
(P = .31). The gestational age at delivery was 37.5 ±
0.4 weeks (mean ± SEM) in the group with prenatal
diagnosis, whereas the patients with a postnatal diag-
nosis were delivered significantly later (39.1 ± 0.2
weeks, P < .001). Apgar scores were not different.
Prostaglandin administration was required in 71% of
both the prenatal and the postnatal patients. In the pre-
natal group prostaglandin was always started on the
first day of life (SEM = 0), and this differed signifi-
cantly from the postnatal group, in which prosta-
glandin was started at 2.6 ± 0.6 days (P < .001). No
difference was found in the dosage or duration of
prostaglandin administration (Table I). Patients with a
prenatal diagnosis stayed in the hospital a mean time
of 15.4 days, and those with a postnatal diagnosis
stayed 19.9 days (P = .55). The difference in outcome
was not significant either. Of the prenatal group, 17%
died within 31 days after birth compared with 19% in
the postnatal group (P = .87).
Laboratory results. Significant differences were
found in the lowest arterial pH (prenatal vs postnatal,
7.31 ± 0.01 vs 7.28 ± 0.01; P = .004) and the lowest pre-
operative BE (prenatal vs postnatal, –4.90 ± 0.45
mEq/L vs –7.26 ± 0.35 mEq/L; P < .001), with acidosis
more common among the postnatally diagnosed group.
Lactate was only measured in the patients seen in
Utrecht because this is not a standard procedure in the 2
American centers in this study. The patients receiving
prenatal and postnatal diagnoses had a highest lactate
value of 3.14 ± 0.57 mmol/L and 6.33 ± 0.58 mmol/L,
respectively (P < .001). No significant differences were
found in highest arterial PCO2 and lowest PO2 (Table II).
Because very few blood gases were obtained 1 and 4
to 6 hours postpartum in the postnatal group, no signif-
icant differences were encountered for pH or BE at
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these times. The only significant difference was for
PCO2 after 1 hour (prenatal vs postnatal, 45.4 ± 2.5 vs
34.1 ± 3.7 mm Hg; P = .015; Table III).
The percentage of patients with markedly abnormal
laboratory results was also compared. Lactate values
over 7.5 mmol/L were found in 8.3% of the patients in
the prenatal group compared with 24.5% in the postna-
tal group (P = .29). The pH was lower than 7.20 in
8.8% of those having prenatal diagnosis and 20.7% of
those having postnal diagnosis (P = .02). BE lower than
–9.0 mEq/L was found in 28.3% in the postnatal group
and in 11.8% in the prenatal group (P = .005).
Ductus-dependent lesions versus non–ductus-
dependent lesions. In the same patient population, a dif-
ference was made between 2 groups, those with (n = 265)
and those without (n = 109) a circulation depending on
the persistence of a ductus arteriosus. When the same set
of variables was compared for these groups, lowest pH
(prenatal vs postnatal, 7.32 ± 0.01 vs 7.27 ± 0.01; P =
.005) and lowest BE (prenatal vs postnatal, –5.15 ± 0.54
vs –7.44 ± 0.45; P = .002) differed significantly in the
ductus-dependent group, whereas only the lowest BE
(prenatal vs postnatal, –4.08 ± 0.87 vs –6.83 ± 0.58; P =
.027) differed in the non–ductus-dependent group.
Single ventricular repair versus biventricular
repair. Differences found between patients in this pop-
ulation requiring a single ventricular repair and those
patients going for a 2-ventricle repair were the percent-
age of prenatal diagnosis made in these groups (uni-
ventricular vs biventricular, 33% vs 14%; P < .001) and
highest PO2 (univentricular vs biventricular, 37.5 ± 1.8
vs 45.0 ± 2.5; P = .018).
Right-sided heart obstruction: Prenatal versus
postnatal diagnosis. When comparing blood gases of
prenatally and postnatally diagnosed infants with a
right ventricular outflow tract obstruction, a significant
difference was found in lowest arterial BE (prenatal vs
postnatal, –4.38 ± 0.69 vs –6.64 ± 0.59; P = .024).
Left-sided heart obstruction: Prenatal versus
postnatal diagnosis. In the group with a left ventricu-
lar outflow tract obstruction, both lowest BE (prenatal
vs postnatal, –5.03 ± 0.78 vs –7.80 ± 0.62; P = .007)
and lowest pH (prenatal vs postnatal, 7.32 ± 0.02 vs
7.27 ± 0.02; P = .027) differed significantly.
Prenatally diagnosed right-sided heart obstruc-
tion versus prenatally diagnosed left-sided heart
obstruction. In comparing patients with a prenatal
diagnosis of right and left ventricular outflow tract
obstruction, significant differences were found in high-
est arterial PO2 (right vs left, 37.2 ± 2.6 vs 48.7 ± 4.0;
P = .038) and highest arterial lactate (right vs left, 3.6
± 0.4 vs 1.3 ± 0.3; P = .024).
Discussion
Prenatal diagnosis of congenital heart disease
demands a high level of skill but one that is achievable
during routine obstetric ultrasonography.13 The most
convincing justification for such an effort would be to
demonstrate that patients with a prenatal diagnosis
have a better chance of a good outcome as a result of
early initiation of therapy.
In 43% of the patients the diagnosis was made before
24 weeks’ gestation, an age at which termination of
pregnancy is still a legal option, but the parents opted
for continuation of the pregnancy with a planned deliv-
ery. Although the number of cesarean deliveries was
not significantly higher, the gestational age at delivery
was significantly lower in infants with a prenatal diag-
nosis, probably because of the planned induction of the
delivery to ensure optimal postnatal care.
Table I. Gestational age at delivery, Apgar scores, and duration of alprostadil administration, alprostadil dose per
minute, and total cumulative dosage of alprostadil
Prenatal diagnosis n Mean SEM P value
Gestational age at delivery (wk) Yes 44 37.45 0.40 <.001
No 90 39.08 0.22
Apgar score, 1 min Yes 43 7.60 0.22 .93
No 95 7.58 0.18
Apgar score, 5 min Yes 43 8.56 0.13 .55
No 95 8.66 0.10
Alprostadil administration (d) Yes 30 4.30 0.40 .44
No 55 4.89 0.52
Alprostadil dose/min (µg · kg–1 · min–1) Yes 36 0.044 0.009 .16
No 66 0.060 0.007
Alprostadil total dose (mg/kg) Yes 29 0.282 0.071 .24
No 51 0.565 0.174
Patients with and without a prenatal diagnosis are compared.
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No difference was found in Apgar scores between
both groups, which could be expected because cardiac
status in the delivery room rarely differed between the
2 groups as a result of ductal patency and the absence
of significant left-to-right shunting before the postnatal
drop in pulmonary vascular resistance.
Total cumulative dosage of alprostadil (prostaglandin
E1) was no different, and therefore no difference in side
effects is to be expected between the 2 patient
groups.14-17 Alprostadil administration was, if required,
always started on the first day of life in the prenatal
group, whereas administration was started after 2.6
days in the postnatal group. This is likely due to the fact
that decreased ductal flow among the infants with a
postnatal diagnosis resulted in the symptoms leading to
initial diagnosis.
Although hypoxemia or ischemia may result in meta-
bolic acidosis, highest PCO2 and lowest PO2 values were
no different between the 2 patient groups, suggesting
that the predominant cause of acidosis is hypoperfusion
rather than hypoxemia with early alprostadil infusion
affecting systemic perfusion.
In our study prenatal diagnosis did lead to a signifi-
cant prevention of deterioration of the acid-base equi-
librium. A positive effect of prenatal detection on sur-
gical outcome has been suggested in previous
reports,8-12 but we could not affirm such a direct effect.
Eapen and colleagues12 analyzed a specific population
with left ventricular outflow tract obstruction and
found a significant difference in BE in first blood gases
in favor of the prenatally diagnosed group. Our study
covers the entire spectrum of congenital heart disease
and reports on representative information about the
actual acidosis obtained at fixed time intervals after
birth or by analyzing worst blood gases and demon-
strates a significant difference in the severity of acido-
sis in favor of the group of patients with a prenatal
diagnosis of congenital heart disease. This outcome
suggests that immediate management of heart disease
facilitated by the prenatal diagnosis of the disease
diminishes acidosis and allows immediate stabilization
of the acid-base equilibrium. Comparison of markedly
abnormal laboratory values shows that a prenatal diag-
nosis helps in prevention of extreme acidosis.
The importance of avoidance of severe metabolic aci-
dosis to prevent brain damage has been suggested in
previous reports. Enhanced acidosis may exaggerate
ischemic, glial, and vascular cell damage because it
accelerates delocalization of protein-bound iron, with
an ensuing free-radical damage to membrane lipids and
proteins.18-21 Prevention of metabolic acidosis might,
in addition, lead to better surgical outcomes.22-25
Postoperative lactate levels are higher for nonsurvivors
and may be a useful predictor of mortality in children
less than 1 year of age.22-25
The comparison of prenatally and postnatally diag-
nosed patients with ductus-dependent lesions showed
significant differences for lowest BE and lowest pH,
and in patients with non–ductus-dependent lesions,
only lowest BE differed significantly in favor of the
prenatal group. This implicates that especially the early
initiation of alprostadil administration in the ductus-
dependent group prevents acidosis, whereas the differ-
ence in the non–ductus-dependent group, although less
significant, suggests that early initiation of medical
care, other than prostaglandin therapy, is another posi-
tive factor of prenatal diagnosis. In most cases, howev-
er, prostaglandin administration can be delayed for 2 to
3 hours after birth because the ductus arteriosus will
normally stay widely patent in the first several hours.
Comparing patients with a future possibility of
biventricular repair to those with an anticipated sin-
gle ventricular repair, the only statement to be made
is the obvious higher percentage of prenatal diagno-
Table II.  Arterial blood gases in the preoperative period
Prenatal diagnosis n Mean SEM P value
Lowest pH Yes 67 7.31 0.01 .004
No 293 7.28 0.01
Lowest BE (mEq/L) Yes 67 –4.90 0.45 <.001
No 291 –7.26 0.35
Highest PCO2 (mm Hg) Yes 41 45.14 2.03 .244
No 88 48.72 1.86
Lowest PO2 (mm Hg) Yes 41 42.90 2.46 .956
No 83 42.68 2.49
Highest lactate (mmol/L) Yes 11 3.14 0.57 <.001
No 99 6.33 0.58
Patients with and without prenatal diagnosis are compared.
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sis in the last group because of the presence of a dis-
tinctly abnormal 4-chamber view, which facilitates
early diagnosis.
The separate analysis of patients with and without
prenatal diagnosis of right-sided heart obstruction, left-
sided heart obstruction, or no obstruction reveals a sig-
nificant difference in lowest BE in favor of the prenatal
group for the right-sided heart obstruction, lowest BE
and pH for left-sided heart obstruction, and no signifi-
cant difference for the group without obstruction. This
indicates that also in the group with right-sided heart
obstruction, prenatal diagnosis has a positive effect on
prevention of metabolic acidosis.
The power of the numbers is small, especially when
groups of patients are separated out, which makes sig-
nificance hard to reach in subgroups. This includes the
important group of transposition of the great arteries,
where Bonnet and colleagues8 showed that prenatal
detection reduced neonatal mortality. Our data did not
allow such a conclusion, although the surgical out-
comes of all patients have been investigated. The num-
ber of influencing parameters, such as different sur-
geons, different institutions, and different protocols
prevented a clean analysis.
In conclusion, prenatal diagnosis diminishes the
development of metabolic acidosis in the newborn
patient with congenital heart disease without an appar-
ent effect on immediate surgical outcome. Although in
this study the differences are significant but small, they
indicate a first step toward a better-controlled preoper-
ative approach, which will allow an optimization of the
preoperative condition of the patient with severe con-
genital heart disease. We postulate that this improve-
ment in preoperative condition may lead to improved
long-term outcome and prevention of cerebral damage
among this fragile group of patients.
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